CN114487176B - Rapid screening method for dangerous substances in aquatic products - Google Patents

Rapid screening method for dangerous substances in aquatic products Download PDF

Info

Publication number
CN114487176B
CN114487176B CN202210055875.6A CN202210055875A CN114487176B CN 114487176 B CN114487176 B CN 114487176B CN 202210055875 A CN202210055875 A CN 202210055875A CN 114487176 B CN114487176 B CN 114487176B
Authority
CN
China
Prior art keywords
acetic acid
mass spectrum
solution
standard curve
screening method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210055875.6A
Other languages
Chinese (zh)
Other versions
CN114487176A (en
Inventor
刘怡君
蒋丹
刘梦遥
丁健
刘杨
赵菲
赵前程
吕泉
曲宝成
胡侠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian Ocean University
Original Assignee
Dalian Ocean University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian Ocean University filed Critical Dalian Ocean University
Priority to CN202210055875.6A priority Critical patent/CN114487176B/en
Publication of CN114487176A publication Critical patent/CN114487176A/en
Application granted granted Critical
Publication of CN114487176B publication Critical patent/CN114487176B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/72Mass spectrometers
    • G01N30/7233Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • G01N30/724Nebulising, aerosol formation or ionisation
    • G01N30/7266Nebulising, aerosol formation or ionisation by electric field, e.g. electrospray
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N2030/022Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027Liquid chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • G01N2030/062Preparation extracting sample from raw material
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81Aquaculture, e.g. of fish

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Dispersion Chemistry (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

The invention belongs to the technical field of quality safety of aquatic products, and particularly relates to a rapid screening method for dangerous substances in an aquatic product. The 39 kinds of veterinary drug residual samples are respectively extracted by acetonitrile (containing 0.1% of acetic acid) and ethyl acetate (containing 0.1% of acetic acid), purified and concentrated by a dispersion solid phase extraction method, and then are quantitatively determined by a liquid chromatography-mass spectrometry-positive mode multi-reaction monitoring method and an external standard method. The method is simple, has low detection cost, and can remarkably improve the operation timeliness and the detection period and improve the detection efficiency.

Description

Rapid screening method for dangerous substances in aquatic products
Technical Field
The invention belongs to the technical field of quality safety of aquatic products, and particularly relates to a rapid screening method for dangerous substances in an aquatic product.
Background
The nonstandard medication of the aquatic product cultivation easily causes the veterinary drug residue of the aquatic product to exceed the standard, and the pesticide residue of the aquatic product feeding easily causes the pesticide residue of the edible part of the aquatic product. The non-standard discharge of harmful substances easily causes pesticide residues in water quality, thereby causing the safety risk of aquatic product quality. The detection method for market monitoring of veterinary drug residues in aquatic products is a detection method for Guan Nong veterinary drug residues in the national standard recommended use method, namely a GB/T method. The following two problems exist in performing the national standard method: firstly, the method has the applicability problem that the existing national standard method matrix is rarely suitable for aquatic product matrix detection; secondly, the problem of missing in a method for simultaneously detecting multiple kinds of risk substances. The existing agricultural and veterinary drug detection methods are all similar drug residue detection methods, and cannot meet the requirements of efficient screening of various types in the actual screening process. Pretreatment of dangerous materials in aquatic products is a necessary experimental operation step of the materials to be tested before the materials are subjected to instrumental analysis, and the pretreatment method generally comprises extraction, purification, concentration and the like. The pretreatment method of the substance to be tested usually adopts a commercial integrated purification small column. The general purification columns for veterinary drug residues are divided into two categories: one type is direct filtration type, and the other type is adsorption elution type. The direct filtration type purifying column filters impurities in the environment of the sample solution to be detected by utilizing the functions of different molecular sizes, ion exchange and the like, so as to achieve the aim of purification. The adsorption elution type purifying column uses high polymer materials to adsorb the object to be detected in the solution to be detected by utilizing the polarity difference of the object to be detected, and then changes the solution environment to desorb the object to be detected so as to realize the purifying purpose. Above-mentioned two kinds of purifying small column, its detection cost is all relatively high, and the price cost still receives purifying the handling capacity influence of small column, and multiple class analyte purifying effect is not good.
Disclosure of Invention
The invention aims to provide the rapid screening method for the dangerous substances in the aquatic products, which has the advantages of simple method and low detection cost, can obviously improve the operation timeliness and the detection period, and improves the detection efficiency, so that the rapid screening method is better suitable for enterprises and market supervision departments and serves for the safety monitoring of the aquatic products.
The invention establishes a high-throughput rapid screening method for various agricultural and veterinary drug residues under aquatic product (fish, shellfish and shrimp) matrixes, is applicable to aquatic product matrixes, realizes high-throughput screening, and can obviously improve detection efficiency.
In order to achieve the above purpose, the technical scheme of the invention is as follows:
a screening method for 39 agricultural and veterinary drug residues in aquatic products, wherein the 39 agricultural and veterinary drugs are as follows: tylosin, tobrazilin, chlorpanaxadiol, clindamycin, norfloxacin, fleroxacin, enoxacin, sparfloxacin, ofloxacin, lomefloxacin, tilmicosin, ractopamine, spray-on-terol, erythromycin, ciprofloxacin, sulfamethazine, sulfachloropyridazine, sulfadoxine, sulfamethoxazole, benzoyl sulfa, sulfamonomethoxine, sulfaquinoxaline, sulfabenzopyrazole, sulfadimethyl pyrimidine, sulfadiazine, sulfapyridine, sulfathiazole, sulfapair-methoxine, sulfamethazine, sulfamethodazine, thiacloprid, ethiprole, piroxicam, lincomycin, salad floxacin, and danofloxacin;
the method comprises the following steps:
(1) Extraction of
Accurately weighing 2.0g of a homogenized aquatic product muscle sample, placing the homogenized aquatic product muscle sample into a 50mL centrifuge tube, sequentially adding 3mL of EDTA buffer solution, 10mL of acetic acid-acetonitrile mixed solution, 4.0g of anhydrous sodium acetate and 1.0g of sodium chloride, carrying out vortex mixing for 1min, carrying out ultrasonic extraction for 10min, standing for 10min, then centrifuging at a speed of 9900r/min at a temperature of 0-4 ℃ for 10min to obtain a first extract, adding 7mL of acetic acid-ethyl acetate mixed solution into the extracted residue, carrying out ultrasonic extraction for 10min, centrifuging at a speed of 9900r/min to obtain a second extract, and combining the two extracts;
(2) Purification of
Adding 0.4g of C18, 0.4g of ethylenediamine-N-Propylsilane (PSA) and 1.2g of anhydrous magnesium sulfate into the extracting solution obtained in the step (1), carrying out vortex mixing for 2min, centrifuging at a rotating speed of 9900r/min for 10min at a temperature of 0-4 ℃, taking all supernatant fluid, adding 5mL of N-hexane into a 50mL centrifuge tube, carrying out vortex mixing for 2min, centrifuging at a rotating speed of 9900r/min at a temperature of 0-4 ℃, and extracting with N-hexane to obtain a purified extracting solution;
(3) Concentrating and redissolving
Accurately measuring 5mL of purified extract, concentrating and redissolving in a 10mL uncovered glass test tube, filtering the extract by a filter membrane, and measuring by high performance liquid chromatography-tandem mass spectrometry.
In the above technical scheme, further, the volume fraction of acetic acid in the acetic acid-acetonitrile mixed solution is 0.1%.
In the above technical scheme, further, the volume fraction of acetic acid in the acetic acid-ethyl acetate mixed solution is 0.1%.
In the above technical solution, in step (2), further, n-hexane is used for extraction at least 3 times.
In the above technical scheme, in the step (3), N is used at normal temperature 2 Blowing the solvent to dryness for concentration; adding acetic acid-acetonitrile mixed solution with the volume fraction of 0.1% of acetic acid for redissolution.
In the above technical solution, further, in the step (3), the high performance liquid chromatography-tandem mass spectrometry adopts a liquid chromatography-mass spectrometer: AB SCIEX 5500Q-trap, external standard method is used for quantification;
the liquid chromatography-tandem mass spectrometry measurement conditions were:
a. chromatographic column: XDB C18.1X100 mm,1.8 μm;
b. mobile phase: a is 2mM ammonium formate 50mM aqueous formic acid solution, B is 2mM ammonium formate 50mM acetonitrile/water (95/5) solution;
c. ion source: an electrospray ion source;
d. scanning mode: scanning positive ions;
e. the detection mode is as follows: monitoring multiple reactions;
f. ionization voltage: 5500v;
g. atomizing gas: 50psi;
h. auxiliary gas: 60psi;
i. air curtain air pressure: 30psi;
j. atomization temperature: 600 ℃;
k. sample injection amount: 10. Mu.L;
flow rate: 0.3mL/min.
In the above technical scheme, further, the preparation method of the mobile phase comprises the following steps:
(1) Mobile phase a: accurately measuring 0.126g of ammonium formate, dissolving in 1000mL of water, adding 2.3mL of formic acid into the solution, shaking uniformly, and performing ultrasonic treatment for 5min;
(2) Mobile phase B: accurately weighing 0.126g of ammonium formate, dissolving in 50mL of water, adding 950mL of acetonitrile and 2.3mL of formic acid into the solution, shaking uniformly, and performing ultrasonic treatment for 5min.
The beneficial effects of the invention are as follows:
compared with a commercial integrated purification small column, the method of the invention utilizes extraction and salting out in addition to adsorption in the purification principle. The problems that when a purifying small column is used, the passage pressure is too large to screen due to the difference of particle sizes in the solution, the fixed treatment capacity of the filler of the purifying column is limited, the detection period is too long, and the steps are complicated are avoided;
the method has the advantages of simple and convenient operation, cost saving, short time consumption, and improvement of detection efficiency while ensuring recovery rate and precision;
the invention uses acetonitrile (containing 0.1% acetic acid) and ethyl acetate (containing 0.1% acetic acid) to extract respectively, and the extraction efficiency is 100%;
EDTA is added in the extraction process, so that the separation degree of the sarcin substances is better, and the recovery rate is improved;
in the purification process, C18 and n-hexane are used for multi-step degreasing, and the influence on resolution and sensitivity of the liquid chromatography-mass spectrometer is reduced.
Drawings
FIG. 1 is a tylosin standard curve and an MRM mass spectrum, a is a standard curve, and b is an MRM mass spectrum;
FIG. 2 is a tilmicosin standard curve and an MRM mass spectrum, wherein a is a standard curve, and b is an MRM mass spectrum;
FIG. 3 shows a standard curve of the cissamycin and an MRM mass spectrum, wherein a is the standard curve, and b is the MRM mass spectrum;
FIG. 4 is a ractopamine standard curve and an MRM mass spectrum, wherein a is a standard curve, and b is an MRM mass spectrum;
FIG. 5 is a standard curve of tobuterol and an MRM mass spectrum, a is a standard curve, and b is an MRM mass spectrum;
FIG. 6 is a standard curve of the spray Butterflyer and an MRM mass spectrum, a is a standard curve, and b is an MRM mass spectrum;
FIG. 7 is a standard curve of chlorpinalin and a MRM mass spectrum, a is a standard curve, and b is a MRM mass spectrum;
FIG. 8 is a lincomycin standard curve and MRM mass spectrum, a is a standard curve, and b is an MRM mass spectrum;
FIG. 9 is a standard curve of erythromycin and a MRM mass spectrum, a is a standard curve, and b is a MRM mass spectrum;
FIG. 10 is a clindamycin standard curve and MRM mass spectrum, a is a standard curve, and b is an MRM mass spectrum;
FIG. 11 is a ciprofloxacin standard curve and an MRM mass spectrum, wherein a is a standard curve, and b is an MRM mass spectrum;
FIG. 12 is a norfloxacin standard curve and an MRM mass spectrum, wherein a is a standard curve and b is an MRM mass spectrum;
FIG. 13 is a standard curve of sarafloxacin and a MRM mass spectrum, a is a standard curve, and b is a MRM mass spectrum;
FIG. 14 is a standard curve of darofloxacin and an MRM mass spectrum, a is a standard curve, b is an MRM mass spectrum;
FIG. 15 is a standard curve of Fluoxacin and an MRM mass spectrum, a is a standard curve, and b is an MRM mass spectrum;
FIG. 16 is a standard curve of enoxacin and a MRM mass spectrum, a is a standard curve, and b is a MRM mass spectrum;
FIG. 17 is a sapafloxacin standard curve and MRM mass spectrum, a is a standard curve, and b is an MRM mass spectrum;
FIG. 18 is a standard curve of ofloxacin and an MRM mass spectrum, a is a standard curve, and b is an MRM mass spectrum;
FIG. 19 is a lomefloxacin standard curve and an MRM mass spectrum, wherein a is a standard curve and b is an MRM mass spectrum;
FIG. 20 is a sulfamethoxazole standard curve and an MRM mass spectrum, wherein a is a standard curve, and b is an MRM mass spectrum;
FIG. 21 is a sulfachloropyridazine standard curve and an MRM mass spectrum, wherein a is a standard curve, and b is an MRM mass spectrum;
FIG. 22 is a sulfadoxine standard curve and an MRM mass spectrum, wherein a is a standard curve and b is an MRM mass spectrum;
FIG. 23 is a sulfamethoxazole standard curve and an MRM mass spectrum, wherein a is a standard curve, and b is an MRM mass spectrum;
FIG. 24 is a standard curve of Sulfadiisooxazole and a MRM mass spectrum, a is a standard curve, and b is a MRM mass spectrum;
FIG. 25 is a standard curve of benzoylsulfonamide and a MRM mass spectrum, a is a standard curve, and b is a MRM mass spectrum;
FIG. 26 is a standard curve of sulfamonomethoxine and a MRM mass spectrum, wherein a is the standard curve and b is the MRM mass spectrum;
FIG. 27 is a sulfaquinoxaline standard curve and an MRM mass spectrum, wherein a is a standard curve, and b is an MRM mass spectrum;
FIG. 28 is a sulfanilamide phenylpyrazole standard curve and an MRM mass spectrum, a is a standard curve, and b is an MRM mass spectrum;
FIG. 29 is a standard curve of sulfadimidine and an MRM mass spectrum, a is a standard curve, and b is an MRM mass spectrum;
FIG. 30 is a sulfadiazine standard curve and an MRM mass spectrum, a is a standard curve, and b is an MRM mass spectrum;
FIG. 31 is a sulfapyridine standard curve and an MRM mass spectrum, a is a standard curve, and b is an MRM mass spectrum;
FIG. 32 is a sulfathiazole standard curve and an MRM mass spectrum, wherein a is a standard curve and b is an MRM mass spectrum;
FIG. 33 is a sulfamethoxydiazine standard curve and an MRM mass spectrum, wherein a is a standard curve, and b is an MRM mass spectrum;
FIG. 34 is a sulfamethazine standard curve and MRM mass spectrum, a is a standard curve, and b is an MRM mass spectrum;
FIG. 35 shows sulfamethoxypyridazine standard curves and MRM mass spectrograms, wherein a is a standard curve, and b is an MRM mass spectrogram;
FIG. 36 is a thiacloprid standard curve and an MRM mass spectrum, a is a standard curve, and b is an MRM mass spectrum;
FIG. 37 is an imidacloprid standard curve and MRM mass spectrum, a is a standard curve, and b is an MRM mass spectrum;
FIG. 38 is a diethofencarb standard curve and MRM mass spectrum, a is a standard curve, and b is an MRM mass spectrum;
FIG. 39 shows the standard curve of pirimicarb and the MRM spectrum, a is the standard curve, and b is the MRM spectrum.
Detailed Description
The following examples will enable those of ordinary skill in the art to more fully understand the invention and are not intended to limit the invention in any way.
Example 1
(1) Standard solution preparation
(1) Preparation of standard stock solution: accurately weighing 10mg of each of tylosin, josamycin, tobuterol, chlorpanaxline, clindamycin, norfloxacin, fleroxacin, enoxacin, sparfloxacin, ofloxacin, lomefloxacin, tilmicosin, ractopamine, plagioterol, erythromycin, ciprofloxacin, sulfamethoxazole, sulfachlorpyridazine, sulfadoxine, sulfamethoxazole, benzoyl sulfa, sulfamonomethoxine, sulfaquinoxaline, sulfabenzene pyrazole, sulfadimethyl pyrimidine, sulfadiazine, sulfapyridine, sulfathiazole, sulfamethazine, sulfamethoxazole, thiacloprid, imidacloprid, diethofencarb, piroxicam, sarafloxacin and dalofloxacin standard samples, and preparing 1000mg/L single standard stock solution by methanol to 10mL respectively, and storing the single standard stock solution at-18 ℃ for future use in a dark place;
(2) mixing standard working solution: the standard stock solution is diluted step by using 20 percent methanol to prepare mixed working solution with the concentration of 1 mug/L, 2 mug/L, 5 mug/L, 8 mug/L and 10 mug/L, and the linear range is 1 to 100 mug/L;
(2) Extraction of
Accurately weighing 2.0g of a homogenized aquatic product muscle sample, placing the homogenized aquatic product muscle sample into a 50mL centrifuge tube, sequentially adding 3mL of EDTA buffer solution, 10mL of acetic acid-acetonitrile solution containing 0.1 percent, 4.0g of anhydrous sodium acetate and 1.0g of sodium chloride, carrying out vortex mixing for 1min, carrying out ultrasonic extraction for 10min, standing for 10min, centrifuging at a speed of 9900r/min at a temperature of 0-4 ℃ for 10min, transferring supernatant into another 50mL centrifuge tube, adding 7mL of acetic acid-ethyl acetate mixed solution into residues, carrying out ultrasonic extraction for 10min, centrifuging at a speed of 9900r/min to obtain a second extracting solution, and combining the two extracting solutions;
(3) Purification of
Adding 0.4g of C18, 0.4g of PSA adsorbent and 1.2g of anhydrous magnesium sulfate into the extracting solution, mixing the mixture with vortex for 2min at the temperature of 0-4 ℃ at the speed of 9900r/min, centrifuging for 10min, taking all supernatant into a 50mL centrifuge tube, adding 5mL of n-hexane, mixing the mixture with vortex for 2min at the temperature of 0-4 ℃ at the speed of 9900r/min, centrifuging for 4min, sucking the upper n-hexane, discarding the upper n-hexane, and repeatedly extracting the n-hexane for at least 3 times;
(4) Concentrating and redissolving
Accurately measuring 5mL of the lower purified extract in a 10mL uncovered glass test tube, and N at normal temperature 2 Blowing to dryness. 1mL of 0.1% acetic acid-acetonitrile solution was reconstituted. Filtering with 0.22 μm organic microporous membrane, and filling the filtrate into sample bottle for detection.
The detection adopts a liquid chromatography-mass spectrometer: AB SCIEX 5500Q-trap, measurement conditions are:
a. chromatographic column: XDB C18.1X100 mm,1.8 μm or equivalent;
b. mobile phase:
phase A: accurately measuring 0.126g of ammonium formate, dissolving in 1000mL of water, adding 2.3mL of formic acid into the solution, shaking uniformly, and performing ultrasonic treatment for 5min to obtain a 2mM ammonium formate 50mM formic acid aqueous solution;
and B phase: accurately measuring 0.126g of ammonium formate, dissolving in 50mL of water, adding 950mL of acetonitrile and 2.3mL of formic acid into the solution, shaking uniformly, and then performing ultrasonic treatment for 5min to obtain a 2mM ammonium formate 50mM acetonitrile/water (95/5) solution;
c. ion source: an electrospray ion source;
d. scanning mode: positive ion scan (esi+);
e. the detection mode is as follows: multiple Reaction Monitoring (MRM);
f. ionization voltage (IS): 5500v;
g. atomizing Gas (Gas 1): 50psi;
h. assist Gas (Gas 2): 60psi;
i. curtain air pressure (CUR): 30psi;
j. atomization Temperature (TEM): 600 ℃;
k. sample injection amount: 10. Mu.L;
flow rate: 0.3mL/min.
(5) Qualitative analysis
Comparing a liquid chromatographic separation spectrogram of a sample solution obtained under the same liquid chromatographic condition with a liquid chromatographic separation spectrogram of a standard substance, and if a chromatographic peak with the retention time consistent with that of a certain standard substance exists in the sample spectrogram, and the ultraviolet absorption spectrum after background subtraction is consistent with that of the standard substance, preliminarily identifying that the substance exists in the sample.
And respectively sampling the standard working solutions of the matrix, preparing a standard working curve by taking the concentration as an abscissa and the peak area as an ordinate, and quantifying the sample by using an external standard method of the standard working curve of the matrix.
The addition concentration of the target substance is 5-50 mug/kg, the recovery rate is 60.2-118.8%, and the RSD is 0.01-11.14%.
The 39 standard reference retention times and the linear equation are shown in table 1.
TABLE 1
Figure BDA0003476452660000071
Figure BDA0003476452660000081
The 39 standard substance standard curves and the MRM mass spectrum are shown in FIG. 1.
The above examples are only preferred embodiments of the present invention and are not limiting of the implementation. The protection scope of the present invention shall be subject to the scope defined by the claims. Other variations or modifications may be made in the various forms based on the above description. Obvious variations or modifications of the embodiments are within the scope of the invention.

Claims (5)

1. A screening method for 39 agricultural and veterinary drug residues in aquatic products is characterized by comprising the following steps:
the 39 agricultural and veterinary drugs are: tylosin, tobrazilin, chlorpanaxadiol, clindamycin, norfloxacin, fleroxacin, enoxacin, sparfloxacin, ofloxacin, lomefloxacin, tilmicosin, ractopamine, spray-on-terol, erythromycin, ciprofloxacin, sulfamethazine, sulfachloropyridazine, sulfadoxine, sulfamethoxazole, benzoyl sulfa, sulfamonomethoxine, sulfaquinoxaline, sulfabenzopyrazole, sulfadimethyl pyrimidine, sulfadiazine, sulfapyridine, sulfathiazole, sulfapair-methoxine, sulfamethazine, sulfamethodazine, thiacloprid, ethiprole, piroxicam, lincomycin, salad floxacin, and danofloxacin;
the method comprises the following steps:
(1) Extraction of
Accurately weighing 2.0g of a homogenized aquatic product muscle sample, placing the homogenized aquatic product muscle sample into a 50mL centrifuge tube, sequentially adding 3mL of EDTA buffer solution, 10mL of acetic acid-acetonitrile mixed solution, 4.0g of anhydrous sodium acetate and 1.0g of sodium chloride, carrying out vortex mixing for 1min, carrying out ultrasonic extraction for 10min, standing for 10min, then centrifuging at a speed of 9900r/min at a temperature of 0-4 ℃ for 8min to obtain a first extract, adding 7mL of acetic acid-ethyl acetate mixed solution into the extracted residue, carrying out ultrasonic extraction for 10min, centrifuging at a speed of 9900r/min to obtain a second extract, and combining the two extracts;
(2) Purification of
Adding 0.4g of C18, 0.4g of ethylenediamine-N-propylsilane and 1.2g of anhydrous magnesium sulfate into the extracting solution obtained in the step (1), carrying out vortex mixing for 2min, then centrifuging at the speed of 9900r/min for 10min at the temperature of 0-4 ℃, taking all supernatant liquid, adding 5mL of N-hexane into a 50mL centrifuge tube, carrying out vortex mixing for 2min, centrifuging at the speed of 9900r/min for 4min at the temperature of 0-4 ℃, and extracting with N-hexane to obtain a purified extracting solution;
(3) Concentrating and redissolving
Accurately measuring 5mL of purified extract in a 10mL uncovered glass test tube, concentrating, redissolving, filtering by an extract filtering membrane, and measuring by high performance liquid chromatography-tandem mass spectrometry;
the detection adopts a liquid chromatography-mass spectrometer: AB SCIEX 5500Q-trap, measurement conditions are:
a. chromatographic column: XDB C18.1X100 mm,1.8 μm or equivalent;
b. mobile phase:
phase A: accurately measuring 0.126g of ammonium formate, dissolving in 1000mL of water, adding 2.3mL of formic acid into the solution, shaking uniformly, and performing ultrasonic treatment for 5min to obtain a 2mM ammonium formate 50mM formic acid aqueous solution;
and B phase: accurately measuring 0.126g of ammonium formate, dissolving in 50mL of water, adding 950mL of acetonitrile and 2.3mL of formic acid into the solution, shaking uniformly, and then performing ultrasonic treatment for 5min to obtain a 2mM ammonium formate 50mM acetonitrile/water (95/5) solution;
c. ion source: an electrospray ion source;
d. scanning mode: positive ion scan (esi+);
e. the detection mode is as follows: multiple Reaction Monitoring (MRM);
f. ionization voltage (IS): 5500v;
g. atomizing Gas (Gas 1): 50psi;
h. assist Gas (Gas 2): 60psi;
i. curtain air pressure (CUR): 30psi;
j. atomization Temperature (TEM): 600 ℃;
k. sample injection amount: 10. Mu.L;
flow rate: 0.3mL/min.
2. The screening method of claim 1, wherein: the volume fraction of acetic acid in the acetic acid-acetonitrile mixed solution is 0.1%.
3. The screening method of claim 1, wherein: the volume fraction of acetic acid in the acetic acid-ethyl acetate mixed solution is 0.1%.
4. The screening method of claim 1, wherein: in the step (2), the extraction is performed at least 3 times by using n-hexane.
5. The screening method of claim 1, wherein: in the step (3), N is used at normal temperature 2 Blowing the solvent to dryness for concentration; adding acetic acid-acetonitrile mixed solution with the volume fraction of 0.1% of acetic acid for redissolution.
CN202210055875.6A 2022-01-18 2022-01-18 Rapid screening method for dangerous substances in aquatic products Active CN114487176B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210055875.6A CN114487176B (en) 2022-01-18 2022-01-18 Rapid screening method for dangerous substances in aquatic products

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210055875.6A CN114487176B (en) 2022-01-18 2022-01-18 Rapid screening method for dangerous substances in aquatic products

Publications (2)

Publication Number Publication Date
CN114487176A CN114487176A (en) 2022-05-13
CN114487176B true CN114487176B (en) 2023-06-16

Family

ID=81512371

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210055875.6A Active CN114487176B (en) 2022-01-18 2022-01-18 Rapid screening method for dangerous substances in aquatic products

Country Status (1)

Country Link
CN (1) CN114487176B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107132291A (en) * 2017-05-22 2017-09-05 河北中医学院 A kind of ultra high efficiency liquid chromatography mass spectrometric combination determines the quantitative approach of 10 kinds of compositions in evodia rutaecarpa granule

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010011899A (en) * 2010-10-29 2012-04-30 Bioderpac S A De C V Mixture and method for quantifying astaxanthin in residues of fermented shrimp using high-performance liquid chromatography (hplc).
CN103076415B (en) * 2011-11-15 2014-08-06 南昌大学 Method for enriching nature tetracycline antibiotics in aquatic products
CN103713056B (en) * 2013-11-25 2015-07-01 宁波出入境检验检疫局检验检疫技术中心 Method for simultaneously analyzing and detecting residual veterinary drug compositions in animal tissue
CN104764844A (en) * 2015-03-18 2015-07-08 谱尼测试科技股份有限公司 Detection method of measuring residue amount of 35 veterinary drugs in meat of poultry and livestock
CN105548446A (en) * 2016-01-30 2016-05-04 崔淑华 Quick GC (Gas Chromatograph)-MS (Mass Spectrometry)/MS determining method of residual quantity of fluxapyroxad
JP6866256B2 (en) * 2016-08-30 2021-04-28 三浦工業株式会社 Method for preparing samples for analysis of residual pesticides
CN107228912A (en) * 2017-05-26 2017-10-03 河南省兽药饲料监察所 The screening method of 79 kinds of antibacterials in a kind of animal food
CN107576744A (en) * 2017-09-29 2018-01-12 沈阳出入境检验检疫局检验检疫综合技术中心 A kind of method for detecting animal derived food veterinary drug residue
CN108008028B (en) * 2017-11-13 2020-08-14 浙江省海洋水产研究所 Dispersed solid phase extraction-gas chromatography-mass spectrometry detection method for phthalate ester environmental hormone in marine products
CN108614046B (en) * 2018-04-26 2021-01-29 中国水产科学研究院长江水产研究所 Method for rapidly extracting and detecting doxycycline and metabolite in aquatic product
CN109633065B (en) * 2018-12-28 2021-04-20 沈阳海关技术中心 Method for detecting drug residues in animal body
CN109917047A (en) * 2019-04-15 2019-06-21 陕西科技大学 The method of multi-class medicament residue in ultra performance liquid chromatography-quadrupole rod time-of-flight mass spectrometry (TOFMS) while screening fish
CN111060638B (en) * 2019-08-31 2022-06-03 河南省兽药饲料监察所(河南省畜产品质量监测检验中心) Screening and confirming method for 207 veterinary drugs and additives in animal food
CN110806452B (en) * 2019-10-17 2022-09-13 佛山科学技术学院 Method for detecting residual content of antiviral drugs in aquatic product meat
CN110927280A (en) * 2019-12-09 2020-03-27 江西科技师范大学 Method for detecting harmful substances in aquatic products in green and high-sensitivity manner
CN111289707A (en) * 2020-03-11 2020-06-16 中国海洋大学 Method for characterizing characteristic taste of steamed fish sample and application
CN111812250A (en) * 2020-08-14 2020-10-23 湖南省食品质量监督检验研究院 Method for rapidly detecting drug residues in aquatic products
CN113219078B (en) * 2021-03-25 2022-12-16 广东产品质量监督检验研究院(国家质量技术监督局广州电气安全检验所、广东省试验认证研究院、华安实验室) Rapid screening method for 17 organic antibacterial agents in household paper products
CN113390989A (en) * 2021-06-10 2021-09-14 成都市食品药品检验研究院 Detection method of veterinary drug residues in fish

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107132291A (en) * 2017-05-22 2017-09-05 河北中医学院 A kind of ultra high efficiency liquid chromatography mass spectrometric combination determines the quantitative approach of 10 kinds of compositions in evodia rutaecarpa granule

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
液质联用法测定川芎茶调丸中阿魏酸等6种成分的含量;张红贵;陈洪岩;孙晓;张小龙;吴启南;;药学与临床研究(第02期);全文 *

Also Published As

Publication number Publication date
CN114487176A (en) 2022-05-13

Similar Documents

Publication Publication Date Title
CN109557206B (en) Method for simultaneously and accurately detecting 45 antibiotics in livestock and poultry manure
Karlberg et al. Extraction based on the flow-injection principle: Part 3. Fluorimetric Determination of Vitamin B1 (Thiamine) by the Thiochrome Method
CN111007185A (en) Method for determining pesticide residue in edible plant enzyme
CN112858503A (en) Method for measuring residual quantity of 10 aminoglycoside antibiotics in eggs
CN104407077A (en) HPLC detection method of MES and NHS residues
CN110702805B (en) UPLC-MSMS detection method for establishing 19 sulfanilamide residues in cultured fish based on ASE method of C18
Wong et al. Gas chromatographic measurement of urinary catecholamines by an electron capture detection procedure
CN114487176B (en) Rapid screening method for dangerous substances in aquatic products
CN112763610B (en) Method for detecting antibiotics in soil
CN113607851A (en) Method for testing 13 shellfish toxins in biological test material
CN109738537B (en) Method for simultaneously extracting various residual medicines in environmental water
CN108445128A (en) A kind of method of carbamates determination of drug residues in birds, beasts and eggs
CN113155991A (en) Method for rapidly determining sulfonamide antibiotics in water by full-automatic online extraction ultra-high performance liquid chromatography-tandem mass spectrometry
CN116183757B (en) Method for measuring residual quantity of cyanamide in grape wine
CN102382155B (en) Rice syrup extractive and application thereof
CN114594179B (en) Method for simultaneously and rapidly extracting and detecting multiple antibiotics in soil
Mu et al. Development and evaluation of a semi-automatic single-step clean-up apparatus for rapid analysis of 18 antibiotics in fish samples
CN112684040A (en) Method for detecting residual quantity of tolterone in milk and milk powder
CN110726787B (en) LC-MS/MS negative ion mode detection method for analyzing seven mogrosides
CN112964812A (en) Method for detecting 8 sweetening agents in dairy product
CN111707763A (en) Method for rapidly detecting chloramphenicol in food
CN111474279A (en) Method and kit for detecting macrolide antibiotic compounds
CN111044636A (en) Analytical method of micafungin content
CN109932415A (en) The relative quantitation method of the method for Analysis of Organic Substances and sugared isomers
CN112782317A (en) Method for simultaneously determining residual quantity of 13 carbamates pesticides in milk

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant